Neogen Corp

$9.135
USD
Last updated on --.
24h volume477.87K
24h highest9.1700 USD
24h lowest8.0420 USD
24h Price movement+3.69%

NEOG recent prices

24 Hours
+3.69%+$0.325
30 days
-5.07%-$0.47
60 days
-7.95%-$0.76
90 days
-9.28%-$0.9

Key data

Previous close8.8100 USD
Market cap1.95B USD
Volume477.87K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-2.8000 USD
Net income (FY)-608.78M USD
Revenue (FY)870.54M USD
Last report dateApr 9, 2026

About Neogen Corp

IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
HeadquartersLANSING
Employees (FY)1.46K
Revenue per employee (FY)597.90K USD
Net income per employee (FY)-418.12K USD
Listed onNasdaq
Official website

NEOG conversion tables

NEOGNEOG
USDUSD
0.5 NEOG4.567 USD
1 NEOG9.135 USD
5 NEOG45.67 USD
10 NEOG91.35 USD
USDUSD
NEOGNEOG
0.5 USD0.054735 NEOG
1 USD0.10947 NEOG
5 USD0.54735 NEOG
10 USD1.094 NEOG

FAQ

NEOG is trading at $9.135, +3.69% over the last 24 hours. Track live moves on the price chart at the top of this page.
The NEOG stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. NEOG is currently trading at $9.135, +3.69% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on NEOG price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. NEOG's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from NEOG; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against NEOG's historical range and other companies in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector.
Neogen Corp's market cap is currently 1.95B USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume477.87K
24h highest9.1700 USD
24h lowest8.0420 USD
24h Price movement+3.69%
NEOGNEOG
USDUSD
Start trade with NEOG Perpetual